[Form 4] COPART INC Insider Trading Activity

Rhea-AI Filing Summary

Copart, Inc. director reports stock option exercise on a Form 4. A company director exercised stock options covering 100,000 shares of Copart common stock on 11/13/2025 at an exercise price of $11.80 per share. Following this transaction, the reporting person directly held 100,000 shares of Copart common stock, and the reported stock option position was reduced to zero. The options were originally granted under the company’s 2007 Equity Incentive Plan and had vested monthly over 12 months after the grant date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Englander Daniel J

(Last) (First) (Middle)

C/O COPART, INC. 14185 DALLAS PARKWAY

SUITE 300

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COPART INC [ CPRT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		M		100,000	A	$11.8	100,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option(1)	$11.8	11/13/2025		M			100,000	(2)	12/17/2025	Common Stock	100,000	$11.8	0	D

Explanation of Responses:

1. 2007 Equity Incentive Plan.

2. Options vested on a monthly basis over the 12 months succeeding the grant date.

Remarks:

	/s/ D. Joseph Meister, attorney-in-fact	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Copart (CPRT) disclose in this Form 4 filing?

The filing reports that a Copart director exercised stock options on 11/13/2025 to acquire 100,000 shares of common stock at an exercise price of $11.80 per share.

Who is the reporting person in the Copart (CPRT) Form 4 and what is their role?

The reporting person is identified as a director of Copart, Inc., as indicated by the checked "Director" box in the relationship section.

How many Copart (CPRT) shares does the insider own after the reported transaction?

After the transaction on 11/13/2025, the reporting person beneficially owned 100,000 shares of Copart common stock in direct ownership.

What were the key terms of the Copart (CPRT) stock options exercised?

The stock options had an exercise price of $11.80 per share and related to 100,000 underlying shares of Copart common stock. They were granted under the 2007 Equity Incentive Plan.

How did the Copart (CPRT) director’s derivative holdings change in this Form 4?

Following the option exercise coded as "M" on 11/13/2025, the number of derivative securities (stock options) reported as beneficially owned became 0, reflecting that the reported options were fully exercised.

When did the Copart (CPRT) stock options vest according to the filing?

The explanation section states that the options vested on a monthly basis over the 12 months succeeding the grant date.

Under which plan were the Copart (CPRT) stock options granted?

The filing notes that the options were granted pursuant to Copart’s 2007 Equity Incentive Plan, as indicated in the explanation of responses.